China Biologic to Attend Jefferies Healthcare Conference on September 27 and 28, 2011 in London

BEIJING, Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it will participate in the Jefferies 2011 Global Healthcare Conference on September 27 and 28, 2011 in London, UK.

Mr. Ming Yin, China Biologic's Vice President of Finance, will present at the conference on Wednesday, September 28 at 5:00pm.

Investors interested in meeting with China Biologic during the conference should please contact their Jefferies representative.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guizhou Taibang Biological Co., and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is one of the leading plasma-based biopharmaceutical companies in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website at www.chinabiologic.com for additional information.

Company contact:

Mr. Y. Tristan Kuo
Chief Financial Officer
China Biologic Products, Inc.
Telephone: +86 53 8620 2206
Email: [email protected]

SOURCE China Biologic Products, Inc.